BHF · Brighthouse Financial, Inc.
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Insurance - Life — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BHF
this stock
Brighthouse Financial, Inc.
|
$2.93B | -21.5% | +43.2% | 4.1 | 11.2% |
|
CILJF
China Life Insurance Co Ltd
|
$105.99B | +11.3% | — | — | 0.0% |
|
MFC
Manulife Financial Corp
|
$72.14B | +19.8% | — | — | 0.9% |
|
MET
Metlife Inc
|
$61.50B | +22.6% | +8.6% | 18.5 | 1.9% |
|
GWLIF
Great-West Lifeco Inc.
|
$58.82B | +33.4% | — | — | 0.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BHF | -5.2% | -15.0% | -14.6% | -4.1% | -21.5% |
| SPY | -1.0% | -1.9% | +14.9% | -1.2% | +11.1% |
| vs SPY | -4.2% | -13.1% | -29.5% | -2.9% | -32.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.